אפופרוסטנול טבע ® 0.5 מ"ג

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

EPOPROSTENOL AS SODIUM 0.5 MG

Mevcut itibaren:

SALOMON,LEVIN & ELSTEIN LTD

ATC kodu:

B01AC09

Farmasötik formu:

POWDER AND SOLVENT FOR SOLUTION FOR INFUSION

Uygulama yolu:

I.V

Tarafından üretildi:

TEVA PARENTERAL MEDICINES INC, USA

Terapötik grubu:

EPOPROSTENOL

Terapötik endikasyonlar:

Epoprostenol Teva is indicated for the long-term intravenous treatment of primary arterial pulmonary hypertension and arterial pulmonary hypertension associated with the scleroderma spectrum of disease in NYHA class III and class IV patients who do not respond to conventional therapy.

Yetkilendirme tarihi:

2009-11-01